OOIR: Observatory of International Research

Papers

(The TQCC of Thrombosis Journal is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow	50
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report	41
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE	39
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?	38
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pe	35
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes	29
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy	27
Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia	25
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome	23
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study	22
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time	21
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis	21
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients	20
Prognostic significance of stress hyperglycemia ratio in patients with type 2 diabetes mellitus and acute coronary syndromes	19
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study	19
Comparison between canine and porcine models of chronic deep venous thrombosis	18
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India	18
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens	18
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study	16
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study	16
The risk factors of liver cirrhosis complicated with portal vein thrombosis and the efficacy and safety of anticoagulant therapy: a meta analysis	15
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance	15
Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism	15
Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis	14
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study	14

Recurrent arterial and venous thrombosis in a 39-year-old male with Factor V Leiden syndrome and aneurysmal disease: a case report and review of the literature	14
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study	13
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis	13
Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on	13
Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial	13
Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant	13
Structure, signal transduction, activation, and inhibition of integrin αIIbβ3	12
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation	12
Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease – a case report	12
A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults	12
Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI	11
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis	11
Exploring the genetic basis between inflammatory bowel disease and venous thromboembolism	11
Incidence, outcomes, and risk factors of Heparin-induced thrombocytopenia in patients undergoing primary and revision knee arthroplasty	11
Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis o	11
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods	11
Association between obstructive sleep apnea and venous thromboembolism recurrence: results from a French cohort	11
Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study	10
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation	10
Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study	10
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency	10
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban	10
A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection	10
Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)	10
Association of inherited thrombophilia mutations and their combinations among palestinian women with unexplained recurrent miscarriage	10
Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension	10
Risk factor analysis and development of nomogram prediction model for central venous catheter-related thrombosis in burn patients: a retrospective observational study	9
Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review	9
Causes of death after first time venous thromboembolism	9
Process and outcome evaluation of a regional pulmonary embolism response team	9
Cancer-Associated Thrombosis (CAT); mechanisms and treatment options	9
Clinical features and risk factors for poor prognosis in malignant tumor patients with pulmonary embolism: a case control study	9
Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery	9
Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study	9
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis	9
Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage	9
Correction: Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study	9
Bleeding and thrombotic events in patients with heparin-induced thrombocytopenia: a two-decade single-center experience in Thailand	9
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy	9
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism	8
Practical approach to thrombocytopenia in patients with sepsis: a narrative review	8
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study	8
Escalating doses of intravenous APAC demonstrate antithrombotic effect in pigs	8
Causal inference of sex hormone-binding globulin on venous thromboembolism: evidence from Mendelian randomisation	8
Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy	8
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis	8
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association	8
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab	8
Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials	8
NETosis and SARS-COV-2 infection related thrombosis: a narrative review	8

Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis	8
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system	8
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion	7
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database	7
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study	7
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia	7
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review	7
A nomogram for individualized prediction of calf muscular venous thrombosis in patients with acute ischemic stroke: a retrospective study	7
Predictors of pulmonary embolism in hospitalized patients with COVID-19	7
A comparative study on early prediction of venous thromboembolism in patients with traumatic brain injury by machine learning model	7
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene	7
The effect of neutrophil extracellular traps in venous thrombosis	7
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review	7
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta	7
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais	7
Deep vein thrombosis in Ethiopia: a systematic review and meta-analysis, 2025	7
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE	7
Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization	7
Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study	6
“Y appearance” infarction: caused by essential thrombocythemia	6
The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study	6
The prevalence and risk factors of pulmonary embolism in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis	6
Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study	6
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome	6
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19	6
Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study	6
External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a re	6
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis	6
Venous thromboembolic disease in admitted blunt trauma patients: what matters?	6
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS4	6
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study	6
Synergistic effects of rivaroxaban and hypothermia or acidosis on coagulation initiation measured with ROTEM®: a prospective observational study	6
Right heart thrombus in transit and peripherally inserted central catheters	5
Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging	5
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study	5
Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro	5
Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry	5
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing	5
Single-leaflet reconstruction surgery for severe chronic lower limb venous insufficiency caused by post-thrombotic syndrome: a case report and literature review	5
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases	5
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study	5
A nomogram model for predicting preoperative DVT in elderly anemic patients undergoing total hip arthroplasty: a retrospective cohort study	5
Causal association between circulating blood cell traits and pulmonary embolism: a mendelian randomization study	5
Risk factors for deep venous thrombosis following total hip arthroplasty: a meta-analysis	5
Time series differences in coagulopathy in mechanically ventilated COVID-19 and bacterial pneumonia patients: a nationwide observational study in Japan	5
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study	5
Thromboembolic events associated with angiogenesis inhibitors: a real-world study of data from the food and drug administration adverse event reporting system (FAERS) database	5
The correlation of lupus anticoagulant and anticardiolipin antibodies with hematological parameters and clinical findings in sickle cell disease at steady state phase	5
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial	5
National trends in venous thromboembolism-related mortality among pancreatic cancer patients in the United States, 1999–2020	5
Genetic and clinical characterization of two families with severe venous thromboembolism due to nonsense mutations in the SERPINC1 gene	5
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic	5
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks	5
Reply to correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden	5
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model	5
Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study	5
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how	5
Clinical characteristics of COVID-19 associated vasculopathic diseases	5
Risk factors for thrombolysis-related intracranial hemorrhage: a systematic review and meta-analysis	5
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma	5
A 11-year-old boy with Blastocystis hominis infection, presents as immune thrombocytopenia	5
Lemierre’s syndrome complicating deep neck abscess: a case report	5
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study	5
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database	5
Anticoagulant management in an antithrombin-deficient pregnant woman with a history of venous thromboembolism: a case report	5